Lead sponsor
Changchun Huayang High-tech Co., Ltd
1 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
1
Trials led
0
Ongoing
288
Total enrollment
13
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
1
Trials by status
Unknown
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Study of Octohydroaminoacridine Succinate Tablets in Patients With Alzheimer's DiseaseAlzheimer's diseasePh 2Unknown288